Interferon–β Induces Hepatocyte Growth Factor in Monocytes of Multiple Sclerosis Patients

• Nicolas Molnarfi ,

  Contributed equally to this work with: Nicolas Molnarfi, Mahdia Benkhoucha

  Affiliations Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland

  ⨯
• Mahdia Benkhoucha ,

  Contributed equally to this work with: Nicolas Molnarfi, Mahdia Benkhoucha

  Affiliations Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland

  ⨯
• Kristbjörg Bjarnadóttir,

  Affiliations Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland

  ⨯
• Catherine Juillard,

  Affiliation Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland

  ⨯
• Patrice H. Lalive

  * E-mail: Patrice.Lalive@hcuge.ch

  Affiliations Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland, Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland, Laboratory Medicine Service, Department of Genetics and Laboratory Medicine, Faculty of Medicine, University Hospital of Geneva, Geneva, Switzerland

  ⨯